Mr Byong Seung Cho
Mr. Byong Seung Cho is a pioneering leader in the field of exosome-based biotechnology and regenerative medicine. With a strong academic foundation, he holds a BSc and MSc in Molecular Biology from Seoul National University, a Techno-MBA from KAIST, and is currently pursuing a PhD in Life Sciences at Kyung Hee University. His career spans over two decades, blending expertise in biotech management, venture capital, and groundbreaking scientific innovation.
As the founder, CEO, and CTO of ExoCoBio Inc., Mr. Cho has spearheaded the development of exosome-derived therapeutics and aesthetic solutions, revolutionizing treatments for skin diseases, wound healing, and hair regeneration. His landmark 2018 study on exosomes for atopic dermatitis marked a turning point in the field. With 70+ patents and 33+ publications, his work spans exosome production, lyophilization, and novel formulations for dermatologic and regenerative applications.
A globally sought-after speaker, Mr. Cho has delivered 100+ lectures at prestigious forums like IMCAS, AMWC, and WCD. His accolades include leading ExoCoBio to commercialize cutting-edge exosome technologies and contributing to the IPOs of biotech giants like Medytox and Viromed.
